BVX-130

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBVX-130

Drug Alias NameBVX-130

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTubulin polymerisation inhibitors

TargetsTubulin

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiVictriX Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBiVictriX Therapeutics Ltd

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A